General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition

International Journal of Cancer

Volumn 137, Issue 3, 2015, Pages 646-657

  Steffen, Annika ^a   Huerta, José Maria ^b,c   Weiderpass, Elisabete ^d,e,f,g   Bueno De Mesquita, H B ^h,i,j,k   May, Anne M ⁱ   Siersema, Peter D ⁱ   Kaaks, Rudolf ^l   Neamat Allah, Jasmine ^l   Pala, Valeria ^m   Panico, Salvatore ⁿ   Saieva, Calogero ^o   Tumino, Rosario ^p   Naccarati, Alessio ^q   Dorronsoro, Miren ^c   Sánchez Cantalejo, Emilio ^c,r   Ardanaz, Eva ^c,s   Quirós, J Ramón ^t   Ohlsson, Bodil ^u   Johansson, Mattias ^v,w   Wallner, Bengt ^v   Overvad, Kim ^x   Halkjær, Jytte ^y   Tjønneland, Anne ^y   Fagherazzi, Guy ^z,aa,ab   Racine, Antoine ^z,aa,ab   Clavel Chapelon, Françoise ^z,aa,ab   Key, Tim J ^ac   Khaw, Kay Tee ^ad   Wareham, Nick ^ad   Lagiou, Pagona ^ae,af,ag   Bamia, Christina ^ae   Trichopoulou, Antonia ^ag,ah   Ferrari, Pietro ^w   Freisling, Heinz ^w   Lu, Yunxia ^j   Riboli, Elio ^j   Cross, Amanda J ^j   Gonzalez, Carlos A ^ai   Boeing, Heiner ^a   more..

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITY OF TROMSØ   (Norway)

^e KAROLINSKA INSTITUTE   (Sweden)

^f CANCER REGISTRY OF NORWAY   (Norway)

^g FOLKHÄLSAN RESEARCH CENTER   (Finland)

^h NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k UNIVERSITY OF MALAYA   (Malaysia)

^l GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^m NATIONAL CANCER INSTITUTE   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^p CIVILE M P AREZZO HOSPITAL   (Italy)

^q Human Genetics Foundation (HuGeF)   (Italy)

^r ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^s INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^t Health Department of the Autonomous Government of Asturias   (Spain)

^u LUND UNIVERSITY HOSPITAL   (Sweden)

^v UMEÅ UNIVERSITY   (Sweden)

^w INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^x AARHUS UNIVERSITY   (Denmark)

^y DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^z INSERM   (France)

^aa UNIVERSITÉ PARIS SACLAY   (France)

^ab IGR   (France)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

^ad UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ae UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^af HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ag BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^ah HELLENIC HEALTH FOUNDATION   (Greece)

^ai BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

more..

Author keywords

abdominal obesity; body mass index; esophageal cancer; gastric cancer; general obesity; waist circumference

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER INCIDENCE; CANCER LOCALIZATION; CARDIA CARCINOMA; CHRONIC DISEASE; CITRUS FRUIT; CONTROLLED STUDY; DENMARK; DIET; EDUCATION; ESOPHAGEAL ADENOCARCINOMA; EUROPE; FEMALE; FOOD INTAKE; FRANCE; FRUIT; GERMANY; GREECE; HIP CIRCUMFERENCE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; NORWAY; PRIORITY JOURNAL; PROCESSED MEAT; PROSPECTIVE STUDY; QUESTIONNAIRE; RED MEAT; RISK FACTOR; SMOKING; SPAIN; STOMACH ADENOCARCINOMA; SUBCUTANEOUS FAT; SWEDEN; UNITED KINGDOM; VEGETABLE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO; ADENOCARCINOMA; CLINICAL TRIAL; COMPLICATION; ESOPHAGEAL NEOPLASMS; FOLLOW UP; HEALTH SURVEY; MIDDLE AGED; MORPHOMETRICS; OBESITY; RISK; STOMACH NEOPLASMS;

ADENOCARCINOMA; ADULT; AGED; BODY MASS INDEX; BODY WEIGHTS AND MEASURES; ESOPHAGEAL NEOPLASMS; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY; OBESITY, ABDOMINAL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84929508529     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29432     Document Type: Article

References (46)

1. Thrift AP, Whiteman DC., The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 2012; 23: 3155-62.
2. Camargo MC, Anderson WF, King JB, et al., Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut 2011; 60: 1644-9.
3. de Martel C, Ferlay J, Franceschi S, et al., Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13: 607-15.
4. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, physical actitivity, and the prevention of cancer: a global perspective. Washington DC: AICR, 2007.
5. Chen Y, Liu L, Wang X, et al., Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev 2013; 22: 1395-408.
6. Park JY, Mitrou PN, Keogh RH, et al., Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study. Int J Obes (Lond) 2012; 36: 107-18.
7. Pischon T, Boeing H, Hoffmann K, et al., General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-20.
8. Pischon T, Boeing H, Weikert S, et al., Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2008; 17: 3252-61.
9. Wang Y, Rimm EB, Stampfer MJ, et al., Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005; 81: 555-63.
10. Yusuf S, Hawken S, Ounpuu S, et al., Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9.
11. Song X, Jousilahti P, Stehouwer CD, et al., Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr 2013; 67: 1298-302.
12. Steffen A, Schulze MB, Pischon T, et al., Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2009; 18: 2079-89.
13. O'Doherty MG, Freedman ND, Hollenbeck AR, et al., A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut 2012; 61: 1261-8.
14. Corley DA, Kubo A, Zhao W., Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 2008; 17: 352-8.
15. Riboli E, Hunt KJ, Slimani N, et al., European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
16. Riboli E, Kaaks R., The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26 (Suppl 1): S6-S14.
17. Haftenberger M, Lahmann PH, Panico S, et al., Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2002; 5: 1147-62.
18. Spencer EA, Appleby PN, Davey GK, et al., Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002; 5: 561-5.
19. Wareham NJ, Jakes RW, Rennie KL, et al., Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003; 6: 407-13.
20. Malfertheiner P, Selgrad M., Helicobacter pylori infection and current clinical areas of contention. Curr Opin Gastroenterol 2010; 26: 618-23.
21. Islami F, Kamangar F., Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 2008; 1: 329-38.
22. Hampel H, Abraham NS, El-Serag HB., Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199-211.
23. Bosetti C, Rosato V, Gallus S, et al., Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol 2012; 23: 1403-15.
24. Tian W, Zhao Y, Liu S, et al., Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev 2010; 19: 288-98.
25. Jacobs EJ, Thun MJ, Bain EB, et al., A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 2007; 99: 608-15.
26. Carneiro F, Moutinho C, Pera G, et al., Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol 2007; 42: 618-27.
27. Expert panel on the Identification E, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998; 68: 899-917.
28. Hu FB,. Obesity epidemiology. New York: Oxford University Press, Inc., 2008.
29. Cameron AJ, Magliano DJ, Soderberg S,. A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obes Rev 2013; 14: 86-94.
30. Neamat-Allah J, Wald D, Husing A, et al., Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging-a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts. PLoS One 2014; 9: e91586.
31. Cameron AJ, Magliano DJ, Shaw JE, et al., The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol 2012; 41: 484-94.
32. Wong H, Yau T., Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? Therap Adv Gastroenterol 2013; 6: 15-31.
33. Singh S, Sharma AN, Murad MH, et al., Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013; 11: 1399-412 e7.
34. El-Serag HB, Hashmi A, Garcia J, Richardson P, Alsarraj A, Fitzgerald S, Vela M, Shaib Y, Abraham NS, Velez M, Cole R, Rodriguez MB, et al., Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut 2014; 63: 220-9.
35. Kramer JR, Fischbach LA, Richardson P, et al., Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol 2013; 11: 373-81 e1.
36. Rubenstein JH, Morgenstern H, Appelman H, et al., Prediction of Barrett's esophagus among men. Am J Gastroenterol 2013; 108: 353-62.
37. Olefson S, Moss SF., Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2015; 18: 23-32.
38. Robertson EV, Derakhshan MH, Wirz AA, et al., Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa. Gastroenterology 2013; 145: 730-9.
39. Quante M, Abrams JA, Wang TC., The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg? Gastroenterology 2013; 145: 708-11.
40. Aleman JO, Eusebi LH, Ricciardiello L, et al., Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology 2014; 146: 357-73.
41. Ishikawa M, Kitayama J, Kazama S, et al., Plasma adiponectin and gastric cancer. Clin Cancer Res 2005; 11: 466-72.
42. Franciosi CM, Piacentini MG, Conti M, et al., IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study. Hepatogastroenterology 2003; 50: 297-300.
43. Thrift AP, Risch HA, Onstad L, et al., Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by mendelian randomization. Clin Gastroenterol Hepatol 2014; 12: 1667-76 e1.
44. Heitmann BL, Lissner L., Hip Hip Hurrah! Hip size inversely related to heart disease and total mortality. Obes Rev 2011; 12: 478-81.
45. Manolopoulos KN, Karpe F, Frayn KN., Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 2010; 34: 949-59.
46. Frayn KN., Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002; 45: 1201-10.